Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 2, 2015New England Journal of MedicineOpen Access

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

View Full Paper
Ask AI
Bookmark
Share

Authors

SASélidji Todagbé AgnandjiCentre de Recherche Médicales de LambarénéAHAngela HuttnerGeneva CollegeMZMadeleine E. ZinserUniversität Hamburg

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Agnandji et al. (2015) studied this question.

synapsesocial.com/papers/6a804ffc04731064ad4718aahttps://doi.org/10.1056/nejmoa1502924
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Functional Role of Type I and Type II Interferons in Antiviral Defense1994 · 2,496 citations
  2. 2The Murine Double-Stranded RNA-Dependent Protein Kinase PKR Is Required for Resistance to Vesicular Stomatitis Virus2000 · 196 citations
  3. 3Epizootiology of Vesicular Stomatitis1957 · 54 citations
  4. 4A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA2015 · 357 citations